Literature DB >> 1817813

Relationship between D-glucose oxidation and glycolysis in tumoral pancreatic islet cells with either rapid or decreased cell growth.

J Camara1, C Galera, I Valverde, W J Malaisse.   

Abstract

The relationship between glucose oxidation and glycolysis was examined in tumoral pancreatic islet cells with either rapid or decreased cell growth. In the control RINm5F cells, the utilization of D-[5-3H]glucose progressively augmented at increasing concentrations of D-glucose (0.2 to 16.7 mM), whereas D-[6-14C]glucose oxidation reached its maximal value at about 3.0 mM D-glucose. The 14CO2/3HOH ratio progressively decreased at increasing hexose concentrations, being about 5-times higher at 0.2 than 10.0-16.7 mM. These experiments were repeated in cells cultured in the presence of D,L-alpha-difluoromethylornithine, which inhibits RINm5F cell proliferation. At 0.2 mM D-glucose, 14CO2 output was severely decreased but 3HOH production little affected, resulting in a marked fall of the 14CO2/3HOH ratio. On the contrary, at 16.7 mM D-glucose, 3HOH formation was more markedly decreased than 14CO2 output, resulting in an increased 14CO2/3HOH ratio. These findings provide a model for the interference of cell growth with D-glucose metabolism in islet cells. Rapid growth causes a preferential stimulation of the Krebs cycle relative to glycolysis at a low glucose concentration, whilst increasing glycolysis more than oxidation at high concentrations of the hexose.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1817813

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  2 in total

1.  Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle.

Authors:  M L Villanueva-Peñacarrillo; A I Alcántara; F Clemente; E Delgado; I Valverde
Journal:  Diabetologia       Date:  1994-11       Impact factor: 10.122

Review 2.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.